March 29, 2024
  • US Food and Drug Administration has approved GSK’s Arexvy, world’s first RSV vaccine for older adults.
  • RSV belongs to the genus Orthopneumovirus within the family Pneumoviridae and order Mononegavirales.
  • It is a common respiratory virus that usually causes mild, cold-like symptoms.
  • It is characterized by its highly contagious naturee., it has a high potential to infect people.
  • Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.
  • It is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children younger than 1 year of age in the United States.
  • RSV is increasingly being recognized as an important pathogen in older adults.
Print Friendly, PDF & Email

© 2024 Civilstap Himachal Design & Development